GENEINFOSEC INC

Boulder, CO · Biotech · Private

Molecular cryptography system that embeds security tags into DNA molecules to encrypt genetic data before sequencing

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · geneinfosec.com

Sector: Biotech
Headquarters: Boulder, CO
Total capital: $3.4M

Federal grants: $2.1M; 3 awards · 2022–2024; Rank in peer group#10 of 326
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $1.4M; 3 awards · Defense; Rank in Biotech#161 of 4373
Granted patents: 2; 4 pending · first 2023; Rank in peer group#58 of 326

Capital timeline

Latest events

Aug 2024Federal contractDefense · Deoxyribonucleic Acid (dna) Security Through Molecular Cryptography$1.2M
Aug 2024Federal grantDefense · Phase II · Deoxyribonucleic Acid (dna) Security Through Molecular Cryptography$1.2M
Dec 2023Federal grantDefense · Phase I · Dna (deoxyribonucleic Acid) Security Through Molecular Cryptography$73K
Dec 2023Federal contractDefense · Dna (deoxyribonucleic Acid) Security Through Molecular Cryptography$73K
Mar 2022Federal grantDefense · Phase II · Molecular Cryptography for DNA$749K
Apr 2021Federal contractDefense · Molecular Cryptography For Dna$47K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 326 peers

Line = median

Biotech · Molecule

Federal grants#10 · top 3%
Granted patents#58 · top 18%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 6

Sep 2, 2025GrantedSecurity Device For Obfuscating And Securing Lab EquipmentUSPTOUS 12,407,658
Jun 6, 2023GrantedConcealing Information Present Within Nucleic AcidsUSPTOUS 11,667,951
Jan 13, 2022PendingA Method For Generating Random Oligonucleotides And Determining Their SequenceUSPTOApplication 17293821

Show all 6 patent records

Security Device For Obfuscating And Securing Lab EquipmentSep 2, 2025 · US 12,407,658Granted
Concealing Information Present Within Nucleic AcidsJun 6, 2023 · US 11,667,951Granted
A Method For Generating Random Oligonucleotides And Determining Their SequenceJan 13, 2022 · Application 17293821Pending
Security Device for Obfuscating and Securing Lab EquipmentApplication 63348659Pending
A Method For Generating Random Oligonucleotides And Determining Their SequenceApplication PCTUS2019063890Pending
Concealing Information Present Within Nucleic AcidsApplication PCTUS2017058076Pending

Cofactor Genomics, Inc.Similar federal contract value in Biotech · $1.4M in contracts
BLOOD CELL STORAGE INCSimilar federal contract value in Biotech · $1.4M in contracts
GLYCOSCIENTIFIC, L.L.C.Similar federal contract value in Biotech · $1.4M in contracts
BIOO SCIENTIFIC CORPORATIONSimilar federal contract value in Biotech · $1.4M in contracts
GT MOLECULAR, INC.Similar federal contract value in Biotech · $1.3M in contracts
GELSANA THERAPEUTICS INCSimilar federal contract value in Biotech · $1.3M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.